Paul Navarre

Paul Navarre is the Chief Executive Officer of Ferring Holding Inc., the U.S. subsidiary of Ferring Pharmaceuticals (The Ferring Group). Ferring Holding Inc. has more than 800 employees and turnover of over $700M. Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. Ferring identifies, develops and markets innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology, women’s health and orthopaedics.
An accomplished senior executive, Mr. Navarre has built a track record of success spanning 25 years including experience in fast-moving consumer goods and pharmaceuticals. He has served in key strategic positions responsible for operations in Europe, Asia, Africa, Middle East and the U.S. A French national, he has lived and worked in France, Italy, the UK, Switzerland and the U.S.A.
Before joining Ferring, Mr. Navarre was President of International Operations for Allergan. He began his career at Procter and Gamble where over 15 years he held multiple leadership positions in the company’s consumer goods and pharmaceuticals divisions.
Mr. Navarre has solid track record of delivering top line growth in the specialty pharmaceutical business through commercial innovation and customer centric approaches. He is recognized as an authentic visionary leader with the ability to attract and manage multi-functional talents.